162 research outputs found
Are Healthcare Choices Predictable? The Impact of Discrete Choice Experiment Designs and Models
© 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research Background: Lack of evidence about the external validity of discrete choice experiments (DCEs) is one of the barriers that inhibit greater use of DCEs in healthcare decision making. Objectives: To determine whether the number of alternatives in a DCE choice task should reflect the actual decision context, and how complex the choice model needs to be to be able to predict real-world healthcare choices. Methods: Six DCEs were used, which varied in (1) medical condition (involving choices for influenza vaccination or colorectal cancer screening) and (2) the number of alternatives per choice task. For each medical condition, 1200 respondents were randomized to one of the DCE formats. The data were analyzed in a systematic way using random-utility-maximization choice processes. Results: Irrespective of the number of alternatives per choice task, the choice for influenza vaccination and colorectal cancer screening was correctly predicted by DCE at an aggregate level, if scale and preference heterogeneity were taken into account. At an individual level, 3 alternatives per choice task and the use of a heteroskedastic error component model plus observed preference heterogeneity seemed to be most promising (correctly predicting >93% of choices). Conclusions: Our study shows that DCEs are able to predict choices—mimicking real-world decisions—if at least scale and preference heterogeneity are taken into account. Patient characteristics (eg, numeracy, decision-making style, and general attitude for and experience with the health intervention) seem to play a crucial role. Further research is needed to determine whether this result remains in other contexts
Men's preferences for prostate cancer screening: A discrete choice experiment
Background: Screening for prostate cancer (PC) may save lives, but overdiagnosis and overtreatment are serious drawbacks. We aimed to determine men's preferences for PC screening, and to elicit the trade-offs they make. Methods: A discrete choice experiment (DCE) was conducted among a population-based random sample of 1000 elderly men (55-75-years-old). Trade-offs were quantified with a panel latent class model between five PC screening aspects: risk reduction of PC-related death, screening interval, risk of unnecessary biopsies, risk of unnecessary treatments, and out-of-pocket costs. Results: The response rate was 46% (459/1000). Men were willing to trade-off 2.0% (CI: 1.6%-2.4%) or 1.8% (CI: 1.3%-2.3%) risk reduction of PC-related death to decrease their risk of unnecessary treatment or biopsy with 10%, respectively. They were willing to pay \[euro]188 per year (CI: \[euro]141-\[euro]258) to reduce their relative risk of PC-related death with 10%. Preference heterogeneity was substantial, with men with higher educational levels having a lower probability to opt for PC screening than men with lower educational levels. Conclusion: Men were willing to trade-off some risk reduction of PC-related death to be relieved of the burden of biopsies or unnecessary treatments. Increasing knowledge on overdiagnosis and overtreatment, especially for men with lower educational levels, is warranted to prevent unrealistic expectations from PC screening. © 2013 Cancer Research UK. All rights reserved
Patients' and urologists' preferences for prostate cancer treatment: A discrete choice experiment
__Abstract__
Background: Patients' preferences are important for shared decision making. Therefore, we investigated patients' and urologists' preferences for treatment alternatives for early prostate cancer (PC). Methods: A discrete choice experiment was conducted among 150 patients who were waiting for their biopsy results, and 150 urologists. Regression analysis was used to determine patients' and urologists' stated preferences using scenarios based on PC treatment modality (radiotherapy, surgery, and active surveillance (AS)), and risks of urinary incontinence and erectile dysfunction.Results:The response rate was 110 out of 150 (73%) for patients and 50 out of 150 (33%) for urologists. Risk of urinary incontinence was an important determinant of both patients' and urologists' stated preferences for PC treatment (P<0.05). Treatment modality also influenced patients' stated preferences (P<0.05), whereas the risk of erectile dysfunction due to radiotherapy was mainly important to urologists (P<0.05). Both patients and urologists preferred AS to radical treatment, with the exception of patients with anxious/depressed feelings who preferred radical treatment to AS. Conclusion: Although patients and urologists generally may prefer similar treatments for PC, they showed different trade-offs between various specific treatment aspects. This implies that urologists need to be aware of potential differences compared with the patient's perspective on treatment decisions in shared decision making on PC treatment
COVID-19 contact Tracing Apps: Predicted Uptake in the Netherlands Based on a Discrete Choice Experiment.
Background: Smartphone-based contact tracing apps can contribute to reducing COVID-19 transmission rates and thereby
support countries emerging from lockdowns as restrictions are gradually eased.
Objective: The primary objective of our study is to determine the potential uptake of a contact tracing app in the Dutch population,
depending on the characteristics of the app.
Methods: A discrete choice experiment was conducted in a nationally representative sample of 900 Dutch respondents. Simulated
maximum likelihood methods were used to estimate population average and individual-level preferences using a mixed logit
model specification. Individual-level uptake probabilities were calculated based on the individual-level preference estimates and
subsequently aggregated into the sample as well as subgroup-specific contact tracing app adoption rates.
Results: The predicted app adoption rates ranged from 59.3% to 65.7% for the worst and best possible contact tracing app,
respectively. The most realistic contact tracing app had a predicted adoption of 64.1%. The predicted adoption rates strongly
varied by age group. For example, the adoption rates of the most realistic app ranged from 45.6% to 79.4% for people in the
oldest and youngest age groups (ie, ≥75 years vs 15-34 years), respectively. Educational attainment, the presence of serious
underlying health conditions, and the respondents’ stance on COVID-19 infection risks were also correlated with the predicted
adoption rates but to a lesser extent.
Conclusions: A secure and privacy-respecting contact tracing app with the most realistic characteristics can obtain an adoption
rate as high as 64% in the Netherlands. This exceeds the target uptake of 60% that has been formulated by the Dutch government.
The main challenge will be to increase the uptake among older adults, who are least
Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
Primary prevention of cardiovascular diseases: a cost study in family practices
Background: Considering the scarcity of health care resources and the high costs associated with cardiovascular diseases, we investigated the spending on cardiovascular primary preventive activities and the prescribing behaviour of primary preventive cardiovascular medication (PPCM) in Dutch family practices (FPs). Methods. A mixed methods design was used, which consisted of a questionnaire (n = 80 FPs), video recordings of hypertension- or cholesterol-related general practitioner visits (n = 56), and the database of Netherlands Information Network of General Practic
Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review
Industry, regulators, health technology assessment (HTA) bodies, and payers are exploring the use of patient preferences in their decision-making processes. In general, experience in conducting and assessing patient preference studies is limited. Here, we performed a systematic literature search and review to identify factors and situations influencing the value of patient preference studies, as well as applications throughout the medical product lifecyle. Factors and situations identified in 113 publications related to the organization, design, and conduct of studies, and to communication and use of results. Although current use of patient preferences is limited, we identified possible applications in discovery, clinical development, marketing authorization, HTA, and postmarketing phases
Protective behaviour of citizens to transport accidents involving hazardous materials: A discrete choice experiment applied to populated areas nearby waterways
Background To improve the information for and preparation of citizens at risk to hazardous material transport accidents, a first important step is to determine how different characteristics of hazardous material transport accidents will influence citizens' protective behaviour. However, quantitative studies investigating citizens' protective behaviour in case of hazardous material transport accidents are scarce. Methods A discrete choice experiment was conducted among subjects (19-64 years) living in the direct vicinity of a large waterway. Scenarios were described by three transport accident characteristics: odour perception, smoke/vapour perception, and the proportion of people in the environment that were leaving at their own discretion. Subjects were asked to consider each scenario as realistic and to choose the alternative that was most appealing to them: staying, seekin
Collecting the Data
AbstractThis chapter discusses aspects related to data collection. It focuses, firstly, on sampling issues and, secondly, on the survey mode. Sampling issues include sample size and the type of sampling that enable precise estimates to be obtained. Regarding the survey mode, discrete choice experiments can be implemented by mail, telephone, face-to-face or web surveys. Each of these survey modes has its advantages and shortcomings. They are described and compared in the course of this chapter, addressing an important decision in the planning process of a discrete choice experiment
Patients’ preferences and willingness-to-pay for postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer treatments after failure of standard treatments
- …